Spots Global Cancer Trial Database for glucarpidase
Every month we try and update this database with for glucarpidase cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Dose Dense Re-challenge of High Dose Methotrexate With Glucarpidase for Relapsed Primary Central Nervous System Lymphoma | NCT05135858 | Primary Central... | Glucarpidase Methotrexate (M... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma | NCT00634322 | Osteosarcoma | glucarpidase leucovorin | 8 Years - 50 Years | BTG International Inc. | |
| High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma | NCT00634322 | Osteosarcoma | glucarpidase leucovorin | 8 Years - 50 Years | BTG International Inc. | |
| Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma | NCT00727831 | Chemotherapeuti... Lymphoma Mucositis Neurotoxicity | glucarpidase leucovorin calc... methotrexate laboratory biom... quality-of-life... radiation thera... | 18 Years - | University College, London | |
| Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate | NCT00018967 | Neurotoxicity Unspecified Adu... Unspecified Chi... | glucarpidase | - | National Cancer Institute (NCI) | |
| Voraxaze for Delayed Methotrexate Clearance | NCT00424645 | Hematologic Mal... Solid Tumor | Voraxaze (Gluca... Placebo | - | M.D. Anderson Cancer Center | |
| Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity | NCT00481559 | Neoplasms | Voraxaze (gluca... | - | BTG International Inc. | |
| Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate | NCT00018967 | Neurotoxicity Unspecified Adu... Unspecified Chi... | glucarpidase | - | National Cancer Institute (NCI) | |
| Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma | NCT03960177 | Osteosarcoma | Glucarpidase Quality-of-Life... | 25 Years - | OHSU Knight Cancer Institute | |
| Dose Dense Re-challenge of High Dose Methotrexate With Glucarpidase for Relapsed Primary Central Nervous System Lymphoma | NCT05135858 | Primary Central... | Glucarpidase Methotrexate (M... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Voraxaze for Delayed Methotrexate Clearance | NCT00424645 | Hematologic Mal... Solid Tumor | Voraxaze (Gluca... Placebo | - | M.D. Anderson Cancer Center | |
| High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma | NCT00634322 | Osteosarcoma | glucarpidase leucovorin | 8 Years - 50 Years | BTG International Inc. | |
| Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate | NCT05899751 | Acute Kidney In... Drug Toxicity | High-dose metho... Glucarpidase | - | BTG International Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
